Search
for
Sort by
Research 121–150 of 180
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Erosive pustular dermatosis (chronic atrophic dermatosis of the scalp and extremities)
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Recent advances in 3D bioprinting of tissues and organs for transplantation and drug screening
- Sox21 Regulates Anapc10 Expression and Determines the Fate of Ectodermal Organ
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- A Comprehensive Review of Acne Vulgaris
- The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- A Transcriptome Sequencing Study on Genome-Wide Gene Expression Differences of Lung Cancer Cells Modulated by Fucoidan
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Sorafenib-Associated Facial Acneiform Eruption
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- Lrig1-expression confers suppressive function to CD4+ cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Erosive Pustular Dermatosis: A Manifestation of Immunosenescence A Report of 8 Cases
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review
- Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Amphiregulin in Fibrotic Diseases and Cancer
- More is not always better in hair growth factors. epidermal growth factor: hair growth factor involved in alopecia areata pathogenesis
- Therapies and nanotherapies for cervical cancer (Review)